Skip to main content
OpenTrials

Clinical trial condition

Lung Diseases, Interstitial

Explore clinical trials studying Lung Diseases, Interstitial. Study availability and eligibility vary by location and protocol.

60 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Lung Diseases, Interstitial trial results

Completed

A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)

NCT05321082

Conditions
Lung Diseases, Lung Diseases, Interstitial, Respiratory Tract Diseases
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Arizona Tucson, Arizona, United States
  • University of Southern California Los Angeles, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
View all 400 locations
View Trial Details
Completed

Developing a Screening Tool for Interstitial Lung Disease in People With Rheumatoid Arthritis Using Risk Factors

NCT05855109

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +9 more
Locations
  • Stanford University School of Medicine Palo Alto, California, United States
  • University of Colorado Aurora, Colorado, United States
  • Harvard Medical School - Brigham and Women's Hospital Boston, Massachusetts, United States
  • University of Michigan Health System Ann Arbor, Michigan, United States
View all 28 locations
View Trial Details
Completed

INCHANGE - Nintedanib for Changes in Cough and Dyspnea in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease With a Progressive Phenotype in Everyday Clinical Practice: a Real-world Evaluation

NCT05151640

Conditions
Lung Diseases, Lung Diseases, Interstitial, Respiratory Tract Diseases
Locations
  • Acibadem City Clinic Tokuda University Hospital EAD Sofia, Bulgaria
  • Medical Military Academy MHAT Sofia Sofia, Bulgaria
  • University Hospital Brno Brno, Czechia
  • University Hospital Brno Brno, Czechia
View all 31 locations
View Trial Details
Completed

Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID-19

NCT06383819

Conditions
COVID-19, Chronic Disease, Coronaviridae Infections, +20 more
Locations
  • State Autonomous Healthcare Institution of the Sverdlovsk region "Aramil City Hospital" Aramil, Russia
  • Private healthcare institution "Clinical Hospital "RZD-Medicine" of the city of Chelyabinsk" Chelyabinsk, Russia
  • State Budgetary Healthcare Institution "Regional Clinical Hospital No. 3" Chelyabinsk, Russia
  • Alliance Biomedical-Ural Group LLC Izhevsk, Russia
View all 30 locations
View Trial Details
Completed

A Study to Test How Well a Medicine Called Nintedanib Helps People in China With Progressive Lung Fibrosis

NCT05065190

Conditions
Lung Diseases, Lung Diseases, Interstitial, Respiratory Tract Diseases
Locations
  • China-Japan Friendship Hospital Beijing, China
  • The Second Hospital of Jilin University Changchun, China
  • Xiangya Hospital, Central South University Changsha, China
  • West China Hospital Chengdu, China
View all 16 locations
View Trial Details
Completed

INREAL - Nintedanib for Changes in Dyspnea and Cough in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease (ILD) With a Progressive Phenotype in Everyday Clinical Practice: a Real-world Evaluation

NCT04702893

Conditions
Lung Diseases, Lung Diseases, Interstitial, Respiratory Tract Diseases
Locations
  • Universitätsklinikum Aachen, AöR Aachen, Germany
  • Pneumologische Praxis Dr. Löh Bad Homburg, Germany
  • ACURA Kliniken Rheinland-Pfalz Bad Kreuznach, Germany
  • Vivantes Klinikum Neukölln Berlin, Germany
View all 21 locations
View Trial Details

Related conditions